DC Advisory advises Cruinn Diagnostics on an investment by Waterland Private Equity
Background
- Cruinn Diagnostics is a leading Irish value-add distributor of clinical diagnostic and pre-analytic laboratory reagents, consumables and equipment. The company offers customers comprehensive equipment servicing, calibration and testing services
- Cruinn Diagnostics is a trusted partner to hospitals, pharmaceuticals, research institutions, and government agencies
- Cruinn Diagnostics has exclusive supply distribution relationships with leading global diagnostics suppliers and is supported by a highly experienced senior leadership team
- MML Ireland invested in Cruinn in 2021
Process
- DC Advisory acted as the exclusive financial advisor to the shareholders of Cruinn Diagnostics on an investment by Waterland Private Equity
- DC Advisory undertook a focused approach to target a buyer universe with sector expertise and financial capacity to support a premium valuation
- DC Advisory led negotiations on the key commercial terms of the transaction, ensuring alignment with shareholder objectives and aiming to maximize value
Outcome
- Waterland Private Equity completed its investment in Cruinn Diagnostics in September 2025
- Financial terms of the transaction were not disclosed
- Cruinn Diagnostics’ ongoing management team will continue to oversee the next stage of its growth with the support of Waterland. Waterland’s management will retain a significant shareholding in Cruinn Diagnostics
- This transaction further illustrates DC Advisory’s expertise in the Healthcare sector
“It was a pleasure to work with David, Robert and the DC Advisory team. From the outset the DC Advisory team assimilated their knowledge of Cruinn’s business and structure to a very high level. This level of knowledge and understanding ensured very fluid and efficient communication throughout the process. DC Advisory’s good advice and guidance was critical in achieving an excellent outcome for all parties and I wish them every success in the future.”
“Jack and the entire Cruinn team have built an outstanding business - differentiated through its unrivalled focus on customer care and broad service offering. We have thoroughly enjoyed working with the team at Cruinn and MML to deliver this transaction, which adds to our strong credentials in the Healthcare Distribution sector.“
- Healthcare
- M&A Advisory
Disclaimer
For more information, please see our transaction disclaimer
For important information regarding testimonials, please see our disclaimer.